# Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

> **NCT05744635** · — · RECRUITING · sponsor: **Chiesi Hungary Ltd.** · enrollment: 110 (estimated)

## Conditions studied

- Liver Failure

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT05744635
- **Lead sponsor:** Chiesi Hungary Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-10
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05744635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05744635, "Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05744635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*